0069-0334 : Litfulo 50 mg Oral Capsule


NDC: 0069-0334
Labeler: Pfizer Laboratories Div Pfizer Inc
Product Type: Human Prescription Drug
Drug Name:  Litfulo
Dosage Form: Oral Capsule
Application #: NDA215830
Rev. Date: 


NDC Package Codes:

  • 0069-0334-28: 28 CAPSULE IN 1 BOTTLE (0069‑0334‑28)

Active Ingredients:

  • Ritlecitinib Tosylate

Dosage Strength:

  • 50 mg

Pharmaceutical Classes:

  • Cytochrome P450 1A2 Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]
  • Janus Kinase 3 Inhibitors [MoA]
  • Kinase Inhibitor [EPC]
  • Tyrosine Kinase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 63539-334 Litfulo 50 mg Oral Capsule by U.S. Pharmaceuticals

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0069-0334 QR Code

< Prev: 0069-0333Next: 0069-0335 >

Related Discussions:

How many people in USA using Sorafenib Tosylate?
Hi, Does anyone know how many people take this medicine in USA? How about its effect? How mean generally how long it can... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.